Tender Overview
The opportunity is issued by the DG Armed Forces Medical Service under the Department Of Defence for a broad list of medicines and injections, including Metronidazole 400 mg tab, Sildenafil 20 mg tab, Insulin Degludec 100 IU/ml pen, Dapagliflozin 5 mg tab, among others. The tender scope covers 46 items across multiple therapeutic categories, with an unresolved estimated value and no explicit delivery location provided. A key differentiator is the 25% quantity option clause, enabling post-award quantity variation at contracted rates. The formal ATC document is uploaded, indicating bidder adherence to buyer terms. Overall, this is a high-visibility defense medical supplies procurement requiring compliant suppliers to address a wide therapeutic portfolio. The tender emphasizes adherence to specific delivery and option-quantity terms while leaving standard item-by-item specifications to the submitted bid and ATC correspondence.
Technical Specifications & Requirements
- Product category: 46 listed medicines and injections (e.g., Metronidazole 400 mg tab; Sildenafil 20 mg tab; Insulin Degludec 100 IU/ml Pen; Glargine 100 IU/ml 3 ml Pen; Dapagliflozin 5 mg tab; Rifaximin 200 mg tab; Fluconazole 150 mg cap; Atenolol 50 mg tab, etc.)
- EMD amount: ₹40,000.
- Delivery terms: Clause supports quantity variation up to 25% of bid quantity at contract time; delivery period aligned to last date of original delivery order with calculated extension formula, minimum 30 days.
- ATC reference: Buyer added ATC document uploaded; compliance with ATC terms required.
- Items coverage: 46 distinct pharmacological products spanning anti-infectives, cardiovasculars, anti-diabetics, antiemetics, analgesics, vaccines/insulins, and other formulations.
- Standards/Certification: Not explicitly specified in data; bidders should anticipate standard pharmaceutical supply compliance and OEM authorizations as per governing procurement terms.
- Delivery/installation: Not specified by item; bidders must rely on ATC terms and buyer guidance for delivery schedule.
- Experience/Capabilities: No explicit years or turnover stated; bidders should prepare to demonstrate capability to supply diverse pharmaceutical catalog under defense procurement protocols.
Terms, Conditions & Eligibility
- EMD: ₹40,000 (Payment terms not detailed here; bidder to verify in ATC).
- Option clause: Up to 25% quantity variation during contract at contracted rates; extended delivery calculations apply.
- Delivery timeline: Initial delivery period defined by last date of original order; extended period governed by option clause with minimum 30 days.
- Documentation: ATC uploaded; bidders must submit as per buyer terms and ATC file guidelines.
- Compliance: Bidder must adhere to the buyer’s defined terms and ensure secure, traceable supply of 46 pharmaceutical items; no location data provided in the extract.
- Quality/Penalties: Penalties or LD provisions not explicit in the provided data; refer to ATC and standard defense procurement policies.